The two-dimensional (2D)13C-13C spin diffusion spectra were recorded using a pulse sequence composed of a 60-kHz1H excitation 90 pulse, a linearly ramped1H-13C cross-polarization period, a 10-kHz rf-assisted diffusion1H field during the 10-ms mixing period, and a 100-kHz1H two-pulse phase modulation decoupling. fibril, phosphorylation, solid state NMR, morphology, structure == Introduction == Amyloid fibrils are -sheet-enriched fibrillar aggregates with misfolded polypeptides and proteins. The formation and deposition of these fibrils are related to a variety of neurodegenerative diseases, including Alzheimer’s disease (AD), 3Parkinson’s disease, and Huntington disease among others (14). Amyloid fibrils derived from the same primary sequences of polypeptides or proteins usually show distinct morphologiesin vitro(5, 6), and the morphologies of fibrils are sensitive to a variety of fibrillation conditions such as temperature (7), agitation (8), salt concentrations (9), surfactant (10), and seeding effects (11). Recent evidence revealed that amyloids can spread through a prion-like mechanism where fibrils seem to play important roles (1214). Different fibrils with their specific morphologies, reminiscent of prion-like strains, may cause distinct pathological phenotypes and link different structures to the variations in disease transmission and pathology (1517). Furthermore, fragmentation of fibrils, Imiquimod (Aldara) which always produces new ends for self- or cross-seeded fibrillation, is of critical importance for infectious amyloids (18, 19). Senile plaques consisting of fibrillar A are considered one of the important hallmarks in AD (20). The 40-residue and 42-residue A peptides (i. e. A40 and A42, respectively) are the two main fibrillar species. Recently, A has also been reported to exhibit prion-like propagation properties (21, 22). Distinct strains of A were discerned in Alzheimer’s patients (2326). Different amyloid propagation properties and structural profiles of A40 and A42 Imiquimod (Aldara) mimic distinct amyloid strains (10, 27). The phenotypes induced by exogenous injection of A-containing brain extracts from Alzheimer’s patients were dependent on both the hosts and the sources of Imiquimod (Aldara) agents, suggesting that polymorphic A strains might result in varying biological activities (25, 28, 29). Molecular structures of A fibrils derived from Alzheimer’s patients with distinct clinical histories were also different (24). This underlines that the structural variations of A fibrils may correlate with the variations of pathological phenotypes (24). In addition , compared with the brain-derived A HMGIC fibrils, the synthetic fibrils showed lower prion activities and different molecular structures (23, 24, 30), implying that some crucial factorsin vivomight account for different fibrillar polymorphisms and pathological phenotypes. Recently, post-translational modifications of A, such as phosphorylation and pyroglutamation, occurringin vivohave been found to promote the progression of AD (31, 32). Among different types of post-translational modifications, the phosphorylation of proteins plays crucial roles in protein folding (33). Phosphorylation can alter the structures of a protein and modulate its activities (33). Using Trp-cage as a model protein, Kardoset al. (34) reported that phosphorylation could serve as a conformational switch to trigger the transition from native to amyloid state. Significantly, we and other groups have demonstrated that phosphorylation is involved in the formation of low barrier hydrogen bond (35) and turn conformations (36) as well as the destabilization of -hairpin structure (37). Furthermore, we have also reported that phosphorylation may modulate the fibrillation process of amyloid proteins, such as Tau and -synuclein (3840). Herein, we describe a novel regulatory function of phosphorylation at Ser8on morphology, biophysical properties, cellular toxicity, and structures of the A40 fibrils. It has been shown that phosphorylation at Ser8in A has important roles in late onset Imiquimod (Aldara) sporadic AD (31, 41, 42). Phosphorylation at Ser8was found in the brains of Alzheimer’s patients in a hierarchical sequence and was specially suggested to be associated with symptomatic AD (43). Phosphorylation at Ser8was modulated by protein kinase A (44). Additionally , this site-specific phosphorylation was known to accelerate the nucleation-dependent fibrillation of A and to enhance the A-mediated amyloid toxicity (44). Attenuation of A clearance via insulin-degrading enzyme and angiotensin-converting enzyme induced by this phosphorylation was also reported (45). Furthermore, the phosphorylation at Ser8could elevate numbers of strong hydrogen bonds in the N terminus of A and increase the stability of the resulting pathogenic fibrils. The latter represents one of the crucial factors for disease progression in the brain (46). Despite all the functional importance, it is not clear whether this residue-specific phosphorylation can modify the morphologies and structures of A Imiquimod (Aldara) fibrils, which are closely related to transmission and progression.
Recent Posts
- Pertaining to amplification of 16S rRNA V3V4 region, the primer 5-TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG-3 and 5-GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGACTACHVGGGTATCTAATCC-3 were used with PCR program since starting with pre-denaturation at 94C for 3min, followed by denaturation at 94C for 30s, annealing at 55C pertaining to 30s, and extension at 72C pertaining to 30s pertaining to 20 cycles with a final extension step at 72C for 8min
- During your time on st
- The experiments were done the two ways
- In: Fragments produced byM
- (D) SFAR4 aminoacids were diagnosed by american blot with specific anti-SFAR4 antibody
Recent Comments
Archives
- August 2026
- July 2026
- June 2026
- May 2026
- April 2026
- March 2026
- February 2026
- January 2026
- December 2025
- November 2025
- June 2025
- May 2025
- March 2025
- February 2025
- January 2025
- December 2024
- November 2024
- October 2024
- September 2024
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
Categories
- Orexin Receptors
- Orexin, Non-Selective
- Orexin1 Receptors
- Orexin2 Receptors
- Organic Anion Transporting Polypeptide
- ORL1 Receptors
- Ornithine Decarboxylase
- Orphan 7-TM Receptors
- Orphan 7-Transmembrane Receptors
- Orphan G-Protein-Coupled Receptors
- Orphan GPCRs
- OT Receptors
- Other Acetylcholine
- Other Adenosine
- Other Apoptosis
- Other ATPases
- Other Calcium Channels
- Other Cannabinoids
- Other Channel Modulators
- Other Dehydrogenases
- Other Hydrolases
- Other Ion Pumps/Transporters
- Other Kinases
- Other MAPK
- Other Nitric Oxide
- Other Nuclear Receptors
- Other Oxygenases/Oxidases
- Other Peptide Receptors
- Other Pharmacology
- Other Product Types
- Other Proteases
- Other Reductases
- Other RTKs
- Other Synthases/Synthetases
- Other Tachykinin
- Other Transcription Factors
- Other Transferases
- Other Wnt Signaling
- OX1 Receptors
- OXE Receptors
- Oxidative Phosphorylation
- Oxoeicosanoid receptors
- Oxygenases/Oxidases
- Oxytocin Receptors
- P-Glycoprotein
- P-Selectin
- P-Type ATPase
- P-Type Calcium Channels
- p14ARF
- p160ROCK
- P2X Receptors
- P2Y Receptors
- p38 MAPK
- p53
- p56lck
- p60c-src
- p70 S6K
- p75
- p90 Ribosomal S6 Kinase
- PAC1 Receptors
- PACAP Receptors
- PAF Receptors
- PAO
- PAR Receptors
- Parathyroid Hormone Receptors
- PARP
- PC-PLC
- PDE
- PDGFR
- PDK1
- PDPK1
- Peptide Receptor, Other
- Peptide Receptors
- Peroxisome-Proliferating Receptors
- PGF
- PGI2
- Phosphatases
- Phosphodiesterases
- Phosphoinositide 3-Kinase
- Phosphoinositide-Specific Phospholipase C
- Phospholipase A
- Phospholipase C
- Phospholipases
- Phosphorylases
- Photolysis
- PI 3-Kinase
- PI 3-Kinase/Akt Signaling
- PI-PLC
- PI3K
- Pim Kinase
- Pim-1
- PIP2
- Pituitary Adenylate Cyclase Activating Peptide Receptors
- PKA
- PKB
- PKC
- PKD
- PKG
- PKM
- PKMTs
- PLA
- Plasmin
- Platelet Derived Growth Factor Receptors
- Platelet-Activating Factor (PAF) Receptors
- Uncategorized